137 related articles for article (PubMed ID: 32010998)
21. DNAM-1 mediates epithelial cell-specific cytotoxicity of aberrant intraepithelial lymphocyte lines from refractory celiac disease type II patients.
Tjon JM; Kooy-Winkelaar YM; Tack GJ; Mommaas AM; Schreurs MW; Schilham MW; Mulder CJ; van Bergen J; Koning F
J Immunol; 2011 Jun; 186(11):6304-12. PubMed ID: 21525383
[TBL] [Abstract][Full Text] [Related]
22. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.
Malamut G; Afchain P; Verkarre V; Lecomte T; Amiot A; Damotte D; Bouhnik Y; Colombel JF; Delchier JC; Allez M; Cosnes J; Lavergne-Slove A; Meresse B; Trinquart L; Macintyre E; Radford-Weiss I; Hermine O; Brousse N; Cerf-Bensussan N; Cellier C
Gastroenterology; 2009 Jan; 136(1):81-90. PubMed ID: 19014942
[TBL] [Abstract][Full Text] [Related]
23. Refractory coeliac disease.
Malamut G; Cellier C
Curr Opin Oncol; 2013 Sep; 25(5):445-51. PubMed ID: 23942290
[TBL] [Abstract][Full Text] [Related]
24. Capsule endoscopy in refractory celiac disease.
Daum S; Wahnschaffe U; Glasenapp R; Borchert M; Ullrich R; Zeitz M; Faiss S
Endoscopy; 2007 May; 39(5):455-8. PubMed ID: 17516353
[TBL] [Abstract][Full Text] [Related]
25. The incidence and clinical spectrum of refractory celiac disease in a north american referral center.
Roshan B; Leffler DA; Jamma S; Dennis M; Sheth S; Falchuk K; Najarian R; Goldsmith J; Tariq S; Schuppan D; Kelly CP
Am J Gastroenterol; 2011 May; 106(5):923-8. PubMed ID: 21468013
[TBL] [Abstract][Full Text] [Related]
26. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
[TBL] [Abstract][Full Text] [Related]
27. TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease.
Perfetti V; Brunetti L; Biagi F; Ciccocioppo R; Bianchi PI; Corazza GR
J Clin Gastroenterol; 2012 Sep; 46(8):675-9. PubMed ID: 22298086
[TBL] [Abstract][Full Text] [Related]
28. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
29. Azathioprine and prednisone combination therapy in refractory coeliac disease.
Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
[TBL] [Abstract][Full Text] [Related]
30. The management of complicated celiac disease.
Al-toma A; Verbeek WH; Mulder CJ
Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
[TBL] [Abstract][Full Text] [Related]
31. Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges.
Scarmozzino F; Pizzi M; Pelizzaro F; Angerilli V; Dei Tos AP; Piazza F; Savarino EV; Zingone F; Fassan M
Front Oncol; 2023; 13():1273305. PubMed ID: 38023263
[TBL] [Abstract][Full Text] [Related]
32. Refractory celiac disease.
Malamut G; Murray JA; Cellier C
Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometry for the assessment and monitoring of aberrant intraepithelial lymphocytes in non-responsive celiac disease and non-celiac enteropathies.
Schiepatti A; Maimaris S; Scarcella C; Pignatti P; Betti E; Shoval Y; Arpa G; Ciccocioppo R; Biagi F
Dig Liver Dis; 2024 May; 56(5):795-801. PubMed ID: 37968145
[TBL] [Abstract][Full Text] [Related]
34. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
[TBL] [Abstract][Full Text] [Related]
35. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
36. Refractory celiac disease: epidemiology and clinical manifestations.
Malamut G; Cellier C
Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
[TBL] [Abstract][Full Text] [Related]
38. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
[TBL] [Abstract][Full Text] [Related]
39. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
40. Refractory celiac disease.
Malamut G; Cellier C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
